Select Medical/$SEM

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Select Medical

Select Medical Holdings Corp is a healthcare company that operates through three segments: critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation clinics. Critical illness recovery hospitals which derives maximum revenue consists of hospitals designed to serve the needs of patients recovering from critical illnesses, often with complex medical needs. The rehabilitation hospital segment consists of hospitals designed to serve patients that require intensive physical rehabilitation care. Patients are typically admitted to critical illness recovery hospitals and rehabilitation hospitals from general acute care hospitals. The outpatient rehabilitation segment consists of clinics that provide physical, occupational, and speech rehabilitation services.

Ticker

$SEM

Primary listing

NYSE

Industry

Health Care Providers & Services

Employees

37,050

ISIN

US81619Q1058

Select Medical Metrics

BasicAdvanced
$1.9B
10.64
$1.37
1.20
$0.38
1.71%

What the Analysts think about Select Medical

Analyst ratings (Buy, Hold, Sell) for Select Medical stock.

Bulls say / Bears say

Select Medical reported a 7.5% increase in revenue for 2024, reaching $5.187 billion, indicating strong operational performance. (prnewswire.com)
The company's Adjusted EBITDA rose by 14.4% to $510.4 million in 2024, reflecting improved profitability. (prnewswire.com)
Analysts have raised the price target for Select Medical's shares to $42.00, citing strong first-quarter performance and an improved forecast for 2024. (investing.com)
The distribution of Concentra resulted in a one-time acceleration of $45.9 million in stock compensation expense, negatively impacting income from continuing operations in 2024. (prnewswire.com)
Despite revenue growth, the outpatient rehabilitation segment's Adjusted EBITDA margin declined to 8.7% in 2024 from 9.4% in the prior year, indicating potential margin pressures. (prnewswire.com)
The company's stock repurchase program did not see any repurchases in the nine months ending September 30, 2024, which may raise concerns about capital allocation strategies. (investing.com)
Data summarised monthly by Lightyear AI. Last updated on 11 Jul 2025.

Select Medical Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Select Medical Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $SEM

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs